Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.

Hu M, Ning J, Mao L, Yu Y, Wu Y

Open source

DOI
10.3892/ol.2026.15853
Published
2026 Nov
Container
Oncology letters
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2026.15853,
  title = {Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.},
  author = {Hu M and Ning J and Mao L and Yu Y and Wu Y},
  year = {2026},
  journal = {Oncology letters},
  doi = {10.3892/ol.2026.15853},
  url = {https://doi.org/10.3892/ol.2026.15853}
}

RIS

TY  - JOUR
TI  - Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.
AU  - Hu M
AU  - Ning J
AU  - Mao L
AU  - Yu Y
AU  - Wu Y
PY  - 2026
JO  - Oncology letters
DO  - 10.3892/ol.2026.15853
UR  - https://doi.org/10.3892/ol.2026.15853
ER  - 

APA

M, H., J, N., L, M., Y, Y., & Y, W. (2026). Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.. Oncology letters. https://doi.org/10.3892/ol.2026.15853

Source records